Guangwei Li
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetes Management and Education
- Diabetes Management and Research
- Pharmacy top 2%
- Obesity and Health Practices
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 18
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Diabetes Treatment and Management 5
-
- Metabolism, Diabetes, and Cancer 8
- Co-authors
- Jinping Wang (23 shared papers)Qiuhong Gong (28 shared papers)Peter H. Bennett (9 shared papers)Yali An (25 shared papers)Wenying Yang (13 shared papers)Yinghua Hu (8 shared papers)Edward W. Gregg (7 shared papers)Ping Zhang (5 shared papers)
- Journals
- Diabetes Obesity and Metabolism (6 papers)Diabetes Research and Clinical Practice (5 papers)Diabetes Care (4 papers)Clinical and Experimental Pharmacology and Physiology (3 papers)Journal of Diabetes (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Guangwei Li
117 papers receiving 2.9k citations
Guangwei Li's Hit Papers
Peers
Comparison fields: 5 of 144
- Endocrinology, Diabetes and Metabolism 1.1k
- Pharmacy 97
- Physiology 428
- Pharmacology 175
- Cardiology and Cardiovascular Medicine 212
Countries citing papers authored by Guangwei Li
This map shows the geographic impact of Guangwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangwei Li more than expected).
Fields of papers citing papers by Guangwei Li
This network shows the impact of papers produced by Guangwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangwei Li. The network helps show where Guangwei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guangwei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study Hit paper breakdown → | 2008 | 1168 |
| 2 | Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study Hit paper breakdown → | 2014 | 453 |
| 3 | 2002 | 80 | |
| 4 | 2015 | 73 | |
| 5 | 2013 | 72 | |
| 6 | 2008 | 63 | |
| 7 | 2020 | 58 | |
| 8 | [Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy]. | 2004 | 45 |
| 9 | 2001 | 44 | |
| 10 | 2009 | 39 | |
| 11 | 2012 | 37 | |
| 12 | 2010 | 34 | |
| 13 | 2010 | 34 | |
| 14 | 2010 | 34 | |
| 15 | 2021 | 31 | |
| 16 | 2011 | 30 | |
| 17 | 2016 | 29 | |
| 18 | 2010 | 28 | |
| 19 | 2011 | 26 | |
| 20 | 2015 | 26 |
About Guangwei Li
Guangwei Li is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery and Physiology, having authored 123 papers that have together received 3.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Metabolism, Diabetes, and Cancer (8 papers), Pancreatic function and diabetes (8 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers), Diabetes Treatment and Management (5 papers), Cardiovascular Health and Risk Factors (4 papers), Nitric Oxide and Endothelin Effects (4 papers) and Geological and Geochemical Analysis (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Pharmacy (97 citations), Physiology (428 citations), Pharmacology (175 citations) and Cardiology and Cardiovascular Medicine (212 citations). Guangwei Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jinping Wang, Qiuhong Gong, Peter H. Bennett, Yali An, Wenying Yang, Yinghua Hu, Edward W. Gregg, Ping Zhang, Ying Shuai and Gojka Roglić. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes Research and Clinical Practice, Diabetes Care, Clinical and Experimental Pharmacology and Physiology and Journal of Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.